Table 1. Demographics and clinical characteristics of all participants.
ESRD (n = 22) | HC (n = 29) | P-value | |
---|---|---|---|
Gender (M/F) | 16/6 | 19/10 | 0.583 a |
Age (yrs) | 38 ± 10.5 (18–61) | 42.1 ± 8.4 (28–61) | 0.127 b |
Education level (yrs) | 11.4 ± 3.3 (4–16) | 12.5 ± 3.4 (6–19) | 0.245 b |
Blood systolic pressure | 155.3 ± 18.3 (102–190) | 110.9± 15.1 (90–145) | <0.001 b |
Blood diastolic pressure | 90.1 ± 7.7 (70–100) | 75.5 ± 6.7 (60–85) | <0.001 b |
Dialysis duration (mths) | 7.4 ±2.2 (2–10) | ||
Cholesterol (mmol/L) | 4.9 ± 1.4 (3.7–9.9) | ||
Serum calciumc | 9.0 ±0.9 (6.8–10.2) | ||
Serum kalium (mmol/L)c | 4.0 ±0.6(2.8–5.5) | ||
Hemoglobin (g/L)c | 95.4±22.6 (53–147) | ||
Serum creatinine (μmol/L)c | 1005.3± 227.6 (672–1357) | ||
Blood urea nitrogen (mmol/L)c | 22.9±7.2 (12.3–36.5) |
Values are represented as mean ± SD (min—max). ESRD, end-stage renal disease; HC, healthy control.
aThe P-value was obtained by chi-square test.
bThe P-value was obtained by two-side two-sample t test.
cData were missing for six patients.